Author

D. Orlicky

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Spengler· 1 shared A.-C. Tan· 1 shared B. Tamburini· 1 shared B. Truong· 1 shared C. Ceol· 1 shared C. Levens· 1 shared C. Sempeck· 1 shared J. Domenico· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Spengler

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MAIT cells drive chronic inflammation in a genetically diverse murine model of spontaneous colitis.

L. Loh, D. Orlicky, A. Spengler, C. Levens, S. Celli, J. Domenico, J. Klarquist, J. Onyiah, J. Matsuda, K. A. Kuhn, L. Gapin

This study investigates the role of MAIT cells in a genetically diverse mouse model of spontaneous colitis, finding that MAIT cells drive chronic inflammation and colonic pathology.

bioRxiv · Nov 29, 2023 · PreprintImmunology

JAK1 inhibition blocks lethal sterile immune responses:implications for COVID-19 therapy

K. Tuttle, R. Minter, K. Waugh, P. Araya, M. Ludwig, C. Sempeck, K. Smith, Z. Andrysik, M. Burchill, B. Tamburini, D. Orlicky, K. D. Sullivan, J. Espinosa

JAK1 inhibition prevents lethal immune responses and organ failure in a mouse model of Down syndrome and viral infection.

bioRxiv · Apr 7, 2020Immunology

Loss of prdm1a accelerates melanoma onset and progression

R. Iwanaga, B. Truong, K. Lambert, R. Vyas, D. Orlicky, Y. Shellman, A.-C. Tan, C. Ceol, K. Artinger

This study shows that loss of PRDM1 accelerates melanoma onset and progression in zebrafish, with reduced PRDM1 expression linked to poor patient survival in humans.

bioRxiv · Dec 20, 2019Cancer Biology